healthcare

Can MEI Pharma Rise Nearly 300%?

MEI Pharma, Inc. (NASDAQ: MEIP) saw its shares make a solid gain on Thursday after the company received a crucial upgrade from Oppenheimer. Most analysts only issue price targets that ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

What to Expect From Eli Lilly at ASCO

In the coming weeks, biotech and pharma companies will descend on Chicago for one of the biggest conferences in 2017. The 2017 annual meeting of the American Society of Clinical ...
Read Full Story »

Why Inovio Pharmaceuticals May Be the Next Big Thing

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) saw a massive gain early on Wednesday after the company announced a critical update from its HIV vaccine. Specifically, the company said that ...
Read Full Story »

What to Expect From Merck at ASCO

The premier event for biotech and pharma companies in 2017 is just around the corner. The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) is set to ...
Read Full Story »

Marijuana News Roundup: Another Push to End Federal Controls on ‘Marihuana’

Last week the lead story in our weekly roundup of cannabis news related the contents of a memo from U.S. Attorney General Jeff Sessions specifying a set of directives establishing ...
Read Full Story »

Marijuana Price Rises to $1,623 a Pound

For the week ended Friday, May 19, 2017, the spot price index for a pound of cannabis rose 2.8% from $1,579 a pound to $1,623. According to the analysts at ...
Read Full Story »

Why Endologix Shares Are Hitting a Multiyear Low

Endologix Inc. (NASDAQ: ELGX) saw its shares hit a multiyear low following a meeting with the U.S. Food and Drug Administration (FDA). After this meeting, the company provided an update ...
Read Full Story »

How ASCO Could Make or Break These 5 Cancer Drug Trials

We are now halfway through May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2017 annual meeting ...
Read Full Story »

Marijuana Sales to Reach Up to $6 Billion This Year

Retail sales of both medical and recreational marijuana are forecast to total $5.1 billion to $6.1 billion in 2017, rising to $11.9 billion to $17.1 billion in 2021, according to ...
Read Full Story »

Why This Humira Patent Loss Might Not Be What You Think

AbbVie Inc. (NYSE: ABBV) watched its shares slide on Wednesday following a ruling from the U.S. Patent and Trade Mark Office Trial and Appeals Board that found in favor of ...
Read Full Story »

Why Syndax Shares Are Rallying

Shares of Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) saw a huge gain on Wednesday after the firm gave an update on its non-small cell lung cancer (NSCLC) midstage trial. Specifically, the ...
Read Full Story »

Why Akebia Shares Are Hitting New Highs

Akebia Therapeutics Inc. (NASDAQ: AKBA) saw its shares hit a new 52-week high in Tuesday’s session following a key licensing agreement with Vifor Pharma. Specifically this is an exclusive license ...
Read Full Story »

Athenex Gears Up for IPO

Athenex has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No pricing details were mentioned in the filing, but the ...
Read Full Story »